This is archived web content selected for preservation by The National Archives. This snapshot was taken on 05/03/2007. See all dates available for this archived website. External links, forms and search boxes may not function within these archived websites.
Find more about web archiving at The National Archives.

Primary Navigation - link to other main sections from here

Skip Navigation

Chlamydia

Genital Chlamydia trachomatis infection is the most commonly diagnosed bacterial sexually transmitted infection in genitourinary medicine (GUM) clinics in the United Kingdom. The number of diagnoses of uncomplicated genital chlamydial infection in GUM clinics has risen steadily since the mid-1990s. The prevalance is highest in sexually active adults, especially women aged 16 to 24 years and men aged 18 to 29 years. As most people are asymptomatic, large proportions of cases remain undiagnosed. Untreated genital chlamydial infection may have serious long-term consequences, especially in women in whom it is a well-established cause of pelvic inflammatory disease (PID), ectopic pregnancy and infertility. The annual cost of chlamydia and its consequences in the United Kingdom is estimated to be more than £100 million.

The National Chlamydia Screening Programme (NCSP)

In this section you can find out about the National Chlamydia Screening Programme (NCSP).



Strategic Evaluation of the 'Pharmacy Chlamydia Screening Pathfinder': Call for Proposals.

Strategic Evaluation of the 'Pharmacy Chlamydia Screening Pathfinder': Call for Proposals

Research Specification - Independent Evaluation of the 'Pharmacy Chlamydia Screening Pathfinder': Background & Policy Context

Application Form - Proposal for Research. Subject to Approved Cost Contracts



Chlamydia useful links

Links to websites about chlamydia.




Global Tools - quick links to useful sections